Details for New Drug Application (NDA): 071587
✉ Email this page to a colleague
NDA 071587 describes LOPURIN, which is a drug marketed by Abbott and Dr Reddys La and is included in three NDAs. It is available from seven suppliers. Additional details are available on the LOPURIN profile page.
The generic ingredient in LOPURIN is allopurinol. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the allopurinol profile page.
The generic ingredient in LOPURIN is allopurinol. There are twenty-two drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the allopurinol profile page.
Summary for 071587
| Tradename: | LOPURIN |
| Applicant: | Dr Reddys La |
| Ingredient: | allopurinol |
| Patents: | 0 |
Pharmacology for NDA: 071587
| Mechanism of Action | Xanthine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 071587
Suppliers and Packaging for NDA: 071587
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LOPURIN | allopurinol | TABLET;ORAL | 071587 | ANDA | Northwind Pharmaceuticals | 51655-782 | 51655-782-26 | 90 TABLET in 1 BOTTLE, PLASTIC (51655-782-26) |
| LOPURIN | allopurinol | TABLET;ORAL | 071587 | ANDA | Northwind Pharmaceuticals | 51655-782 | 51655-782-52 | 30 TABLET in 1 BOTTLE, PLASTIC (51655-782-52) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
| Approval Date: | Apr 2, 1987 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
